# Contact Safe Sermorelin: Reach the Sermorelin Research Digest

> Contact Safe Sermorelin, the editorial sermorelin research digest. Editorial and correction inquiries only — we do not provide medical advice or sell any product.

For editorial questions and corrections about the sermorelin research digest. Not a clinic, not a pharmacy, not a help line.

## Editorial inquiries

Use the form below to reach the editorial team of Safe Sermorelin — the sermorelin research digest — about a citation, a correction, or a question on how a study was summarized. We read every message and we value source-level corrections especially: if a figure on the site does not match the study behind it, tell us which page and which number, and we will check it against the original. Pointers to newer peer-reviewed sermorelin or GHRH-analog research are welcome too; the field moves, and a digest is only as current as the literature it tracks.

## What we cannot help with

We cannot offer medical advice, dosing guidance, diagnosis, or treatment recommendations, and we cannot tell you whether sermorelin is appropriate for any individual — those are questions for a licensed clinician, not an editorial publisher. We do not sell, source, supply, or price any product, and we cannot help with purchasing, prescriptions, or compounding. We also cannot recommend a vendor, evaluate a supplier, or comment on the quality of any particular preparation. Messages asking for any of those will not receive a substantive reply.

For questions of safety, half-life, body composition, or study interpretation, the answers we can offer are already on the site, each cited to its source: the research page, the half-life page, the body-composition page, and the frequently asked questions about sermorelin. If something there is unclear or appears to misread a study, that is exactly the kind of note we want.

## Contact form

Send a short message using the form below. Including the page name and the citation number you are asking about helps us route your note to the right place on the board and reply faster.

[contact-form]

---

A transit-board reading of the sermorelin literature — the GHRH(1-29) findings routed line by line, each GH and IGF-1 figure carried back to its study, the body-composition evidence marked as tesamorelin where it belongs, and the stop where the long-term adult data run out left openly unserviced; no clinic at this board and nothing here dosed, dispensed, or sold.